WuXi AppTec (2359) Fundamentals 2026 — P/E 17.8x, Revenue Analysis | SniperIQ

56.70 on the HKSE. This SniperIQ fundamentals page covers WuXi AppTec's valuation (P/E 17.8x, P/B 4.4x), profitability (net margin 41.7%), revenue (¥45.5B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Full research coverage

• 8-Quarter Revenue & Margin Trend
• Debt Maturity & Coverage
• Peer Valuation Comparison
• Free Cash Flow & Owner Earnings
• AI Signal + Institutional Flow
• DCF Valuation Model

Frequently Asked Questions

What is WuXi AppTec's market cap?

WuXi AppTec (2359) has a market capitalization of approximately HK$451.0B, trading at HK

56.70 on the HKSE. Market cap moves with the live share price.

What is WuXi AppTec's P/E ratio?

WuXi AppTec's trailing twelve-month P/E ratio is 17.8x, with a price-to-book (P/B) of 4.4x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is WuXi AppTec?

WuXi AppTec runs a net profit margin of 41.7%, a gross margin of 49.2%, and an operating margin of 42.7%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does WuXi AppTec generate?

WuXi AppTec reported revenue of ¥45.5B for fiscal year 2025, with net income of ¥19.2B and earnings per share (EPS) of 6.7. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does WuXi AppTec pay a dividend?

WuXi AppTec offers a trailing dividend yield of about 1.5%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.

Is WuXi AppTec financially healthy?

WuXi AppTec carries a debt-to-equity ratio of 0.10x and a current ratio of 3.42x, with a market beta of 0.46. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is WuXi AppTec a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For WuXi AppTec (2359) the key facts are: market cap HK$451.0B, P/E 17.8x, revenue ¥45.5B, 52-week range 91.8-167.6. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.